Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: OPENCELL BIOMED, INC.
CIK: 1385596
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2011-10-24
Last Filing Date: 2011-10-24
SEC Filings
Start End Frame Filed ACCN Value View
2011-06-01 2011-08-31 CY2011Q3 2011-10-24 0001204459-11-002798 $ 26,140,000 View
SEC Facts By Type
Type Name Description View
us-gaap Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Bank Overdrafts Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
us-gaap Due to Related Parties, Current Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Foreign Currency Transaction Gain (Loss), before Tax Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Income Taxes Paid The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. View
us-gaap Increase (Decrease) in Other Operating Liabilities Amount of increase (decrease) in operating liabilities classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Legal Fees The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap License Costs (Deprecated 2018-01-31) Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity, net of tax. View
us-gaap Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. View
us-gaap Other General Expense Amount of general expenses not normally included in Other Operating Costs and Expenses. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. View
us-gaap Professional Fees A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Stock Repurchased and Retired During Period, Shares Number of shares that have been repurchased and retired during the period. View
us-gaap Stock Repurchased and Retired During Period, Value Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
Chart of Accounts => Accounts
Name View
Increase (Decrease) in Other Operating Liabilities View
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) View
Accounts Payable, Current View
Accumulated Other Comprehensive Income (Loss), Net of Tax View
Additional Paid in Capital View
Assets View
Assets, Current View
Bank Overdrafts View
Cash View
Cash and Cash Equivalents, Period Increase (Decrease) View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Comprehensive Income (Loss), Net of Tax, Attributable to Parent View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Due to Related Parties, Current View
Earnings Per Share, Diluted View
Foreign Currency Transaction Gain (Loss), before Tax View
General and Administrative Expense View
Income Taxes Paid View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Prepaid Expense View
Interest Expense View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Issuance of Stock and Warrants for Services or Claims View
Legal Fees View
Liabilities and Equity View
Liabilities, Current View
License Costs (Deprecated 2018-01-31) View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Operating Income (Loss) View
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent View
Other General Expense View
Proceeds from Issuance of Common Stock View
Proceeds from Related Party Debt View
Professional Fees View
Research and Development Expense View
Revenues View
Shares, Issued View
Stockholders' Equity Attributable to Parent View
Stock Repurchased and Retired During Period, Shares View
Stock Repurchased and Retired During Period, Value View
Weighted Average Number of Shares Outstanding, Diluted View